Tag: Pfizer and Biontech Announce Publication of Results from Landmark phase 3 Trial of BNT162B2 COVID-19 vaccine Candidate in the New England Journal of Medicine

Submit guest post/Letters to the Editor:

editor (at) finchannel.com

Sales & Marketing: (+99532) 2252 275 | 76 EXT: 1 (+995 558) 03 03 03 (mobile) marketing (at) finchannel.com

Whatsup: +995599965252

USA:

Georgia:

(+99532) 2252 275 | 76 EXT: 7 (+995599) 96 52 52 Email: zviadi (@) finchannel.com

Postal address: 17 Mtskheta str. Tbilisi, Georgia 0179 The FINANCIAL